<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1228" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1228/" /><meta name="ncbi_pagename" content="SOST-Related Sclerosing Bone Dysplasias - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>SOST-Related Sclerosing Bone Dysplasias - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="SOST-Related Sclerosing Bone Dysplasias" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/03/21" /><meta name="citation_author" content="Natasha Appelman-Dijkstra" /><meta name="citation_author" content="Antoon Van Lierop" /><meta name="citation_author" content="Socrates Papapoulos" /><meta name="citation_pmid" content="20301406" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1228/" /><meta name="citation_keywords" content="van Buchem Disease" /><meta name="citation_keywords" content="Sclerosteosis" /><meta name="citation_keywords" content="Sclerostin" /><meta name="citation_keywords" content="SOST" /><meta name="citation_keywords" content="SOST-Related Sclerosing Bone Dysplasias" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="SOST-Related Sclerosing Bone Dysplasias" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Natasha Appelman-Dijkstra" /><meta name="DC.Contributor" content="Antoon Van Lierop" /><meta name="DC.Contributor" content="Socrates Papapoulos" /><meta name="DC.Date" content="2019/03/21" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1228/" /><meta name="description" content="SOST-related sclerosing bone dysplasias include sclerosteosis and van Buchem disease, both disorders of progressive bone overgrowth due to increased bone formation." /><meta name="og:title" content="SOST-Related Sclerosing Bone Dysplasias" /><meta name="og:type" content="book" /><meta name="og:description" content="SOST-related sclerosing bone dysplasias include sclerosteosis and van Buchem disease, both disorders of progressive bone overgrowth due to increased bone formation." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1228/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/sost/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1228/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D611CE0413D510000000001960095.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1228_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1228_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/slc6a3-dtds/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/sox2/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1228_"><span class="title" itemprop="name"><i>SOST</i>-Related Sclerosing Bone Dysplasias</span></h1><p class="contrib-group"><span itemprop="author">Natasha Appelman-Dijkstra</span>, MD, PhD, <span itemprop="author">Antoon Van Lierop</span>, MD, PhD, and <span itemprop="author">Socrates Papapoulos</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1228_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1228_ai__"><div class="contrib half_rhythm"><span itemprop="author">Natasha Appelman-Dijkstra</span>, MD, PhD<div class="affiliation small">Leiden Center for Bone Quality<br />Leiden University Medical Center<br />Leiden, Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmul@artskjid-namleppa.m.n" class="oemail">ln.cmul@artskjid-namleppa.m.n</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Antoon Van Lierop</span>, MD, PhD<div class="affiliation small">Leiden Center for Bone Quality<br />Leiden University Medical Center<br />Leiden, Netherlands</div><div class="affiliation small">Onze Lieve Vrouwen Gasthuis<br />Amsterdam, Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.gvlo@poreilnav.m.j.h.a" class="oemail">ln.gvlo@poreilnav.m.j.h.a</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Socrates Papapoulos</span>, MD, PhD<div class="affiliation small">Professor of Medicine<br />Leiden Center for Bone Quality<br />Leiden University Medical Center<br />Leiden, Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmul@soluopapap.e.s" class="oemail">ln.cmul@soluopapap.e.s</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 4, 2002</span>; Last Update: <span itemprop="dateModified">March 21, 2019</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="sost.Summary" itemprop="description"><h2 id="_sost_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>SOST</i>-related sclerosing bone dysplasias include sclerosteosis and van Buchem disease, both disorders of progressive bone overgrowth due to increased bone formation.</p><p>The major clinical features of sclerosteosis are progressive skeletal overgrowth, most pronounced in the skull and mandible, and variable syndactyly, usually of the second (index) and third (middle) fingers. Affected individuals appear normal at birth except for syndactyly. Facial distortion due to bossing of the forehead and mandibular overgrowth is seen in nearly all individuals and becomes apparent in early childhood with progression into adulthood. Hyperostosis of the skull results in narrowing of the foramina, causing entrapment of the seventh cranial nerve (leading to facial palsy) with other, less common nerve entrapment syndromes including visual loss (2nd cranial nerve), neuralgia or anosmia (5th cranial nerve), and sensory hearing loss (8th cranial nerve). In sclerosteosis, hyperostosis of the calvarium reduces intracranial volume, increasing the risk for potentially lethal elevation of intracranial pressure. Survival of individuals with sclerosteosis into old age is unusual, but not unprecedented.</p><p>The manifestations of van Buchem disease are generally milder than sclerosteosis and syndactyly is absent; life span appears to be normal.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>SOST</i>-related sclerosing bone dysplasia is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical and radiographic findings and identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SOST</i> (for sclerosteosis) or the presence of a biallelic 52-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> downstream of <i>SOST</i> (for van Buchem disease) on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p>No specific treatment is currently available, and management aims at relieving symptoms and preventing complications.</p><p><i>Treatment of manifestations:</i> Surgical correction of syndactyly; surgical decompression of entrapped cranial nerves, notably the facial nerve; craniectomy and ventriculo-peritoneal drain for increased intracranial pressure; surgical reduction of mandibular overgrowth; hearing aids with middle ear surgery or cochlear implant depending on nature of hearing loss; spinal cord decompression for radiculopathy; orbital decompression for proptosis or glaucoma.</p><p><i>Surveillance:</i> At least annual assessments from infancy for bone mass, evidence of cranial nerve entrapment and of increased intracranial pressure, vision issues, hearing loss, and tooth malalignment/malocclusion.</p><p><i>Agents to avoid:</i> Agents known to suppress bone resorption (e.g., bisphosphonates, denosumab, selective estrogen receptor modulators) and agents known to stimulate bone formation (e.g., teriparatide, abaloparatide, romozosumab).</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>SOST</i>-related sclerosing bone dysplasia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Prenatal diagnosis for pregnancies at increased risk and preimplantation diagnosis for <i>SOST</i>-related sclerosing bone dysplasias are possible if the pathogenic variants in the family have been identified. Ultrasound examination may detect syndactyly in fetuses at risk for sclerosteosis, but its absence on ultrasound examination does not rule out an affected fetus.</p></div></div><div id="sost.GeneReview_Scope"><h2 id="_sost_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="sost.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1228/table/sost.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sost.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sost.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>SOST</i>-Related Sclerosing Bone Dysplasias: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_sost.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Sclerosteosis</div></li><li class="half_rhythm"><div>van Buchem disease</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#sost.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="sost.TF.d.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#sost.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="sost.Diagnosis"><h2 id="_sost_Diagnosis_">Diagnosis</h2><p>Sclerosteosis and van Buchem disease are both disorders of progressive bone overgrowth due to increased bone formation; they are clinically and radiographically similar disorders that are caused by pathogenic variants in <i>SOST</i> [<a class="bk_pop" href="#sost.REF.balemans.2001.537">Balemans et al 2001</a>, <a class="bk_pop" href="#sost.REF.brunkow.2001.577">Brunkow et al 2001</a>, <a class="bk_pop" href="#sost.REF.balemans.2002.91">Balemans et al 2002</a>, <a class="bk_pop" href="#sost.REF.staehlinghampton.2002.144">Staehling-Hampton et al 2002</a>]. The two disorders differ in severity and in type of molecular genetic variants.</p><div id="sost.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>SOST</i>-related sclerosing bone dysplasias <b>should be suspected</b> in individuals with the following findings.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Generalized progressive skeletal overgrowth, most pronounced in the skull and mandible, leading to:</div><ul><li class="half_rhythm"><div>Potentially lethal elevation of intracranial pressure in childhood or early adulthood as a result of calvarial overgrowth</div></li><li class="half_rhythm"><div>Entrapment of the seventh cranial nerve leading to recurrent facial palsy that is initially intermittent and eventually constant, resulting in impaired facial movements in adulthood</div></li><li class="half_rhythm"><div>Conductive hearing loss in childhood followed by additional entrapment of the eighth cranial nerve and closure of the oval and round windows, leading to sensorineural hearing loss in adulthood</div></li><li class="half_rhythm"><div>Distortion of the face with asymmetric mandibular hypertrophy, frontal bossing, midface hypoplasia, or proptosis</div></li><li class="half_rhythm"><div>Tall stature with accelerated bone growth beginning in childhood</div></li></ul></li><li class="half_rhythm"><div>Variable cutaneous or bony syndactyly of fingers two (index) and three (middle), and occasionally fingers three and other fingers. The syndactyly is usually bilateral but not necessarily symmetric. (Note: Syndactyly is not found in van Buchem disease.)</div></li><li class="half_rhythm"><div>Radial deviation of the terminal phalanges</div></li><li class="half_rhythm"><div>Dysplastic or absent nails</div></li></ul><p><b>Radiographic findings</b></p><ul><li class="half_rhythm"><div>Widening (hyperostosis) and increased density (sclerosis) of the calvarium, the base of the skull, and the shafts of the tubular bones</div></li><li class="half_rhythm"><div>Undermodeling of the shafts of the tubular bones of the metacarpals and phalanges</div></li><li class="half_rhythm"><div>Broad and dense clavicles and ribs</div></li><li class="half_rhythm"><div>Sclerosis of the scapulae and pelvis without an increase in size</div></li><li class="half_rhythm"><div>High bone mineral density (Z-score &#x0003e;5) measured by dual energy x-ray absorptiometry (DXA) [<a class="bk_pop" href="#sost.REF.van_lierop.2017.51">van Lierop et al 2017</a>]</div></li></ul><p><b>Ethnicity and neonatal findings.</b> The majority of persons <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with sclerosteosis are members of the Afrikaner (Dutch ancestry) population of South Africa. Within this population the diagnosis should be suspected in any neonate with syndactyly, or in the presence of fluctuating facial palsy.</p><p>Van Buchem disease is almost exclusively found within the Netherlands. There are no specific neonatal findings in patients with van Buchem disease, although facial palsy can already be present at birth [<a class="bk_pop" href="#sost.REF.van_egmond.2012.740">van Egmond et al 2012</a>].</p></div><div id="sost.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>SOST</i>-related sclerosing bone dysplasia <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical and radiographic findings and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants involving <i>SOST</i> identified on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1228/table/sost.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figsostTmoleculargenetictestingusedin" rid-ob="figobsostTmoleculargenetictestingusedin">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis, <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>SOST</i>-related sclerosing bone dysplasia is broad, individuals with the distinctive findings described in <a href="#sost.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#sost.Option_1">Option 1</a>), whereas those with atypical findings in whom the diagnosis of <i>SOST</i>-related sclerosing bone dysplasia has not been considered are more likely to be diagnosed using genomic testing (see <a href="#sost.Option_2">Option 2</a>).</p><div id="sost.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of <i>SOST</i>-related sclerosing bone dysplasia, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>SOST</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected.</div><div class="half_rhythm">Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SOST</i> and other genes of interest (see <a href="#sost.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For this disorder a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that also includes <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> is recommended (see <a class="figpopup" href="/books/NBK1228/table/sost.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figsostTmoleculargenetictestingusedin" rid-ob="figobsostTmoleculargenetictestingusedin">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><p>Note: A <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> 52-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> downstream of <i>SOST</i>, which does not overlap the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a>, has been described in all individuals with van Buchem disease [<a class="bk_pop" href="#sost.REF.balemans.2002.91">Balemans et al 2002</a>, <a class="bk_pop" href="#sost.REF.staehlinghampton.2002.144">Staehling-Hampton et al 2002</a>]. This defect will not be found with single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing or in a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>. However, because van Buchem disease is almost exclusively found in the Netherlands, it is recommended to test for this genetic defect in non-Dutch individuals only if no genetic defects were found in a multigene panel.</p></div><div id="sost.Option_2"><h4>Option 2</h4><p>When the diagnosis of <i>SOST</i>-related sclerosing bone dysplasia is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <b><a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a></b> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="sost.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>SOST</i>-related Sclerosing Bone Dysplasia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1228/table/sost.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sost.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sost.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_sost.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_sost.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_sost.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SOST</i></td><td headers="hd_h_sost.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_sost.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">All reported&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_sost.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_sost.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnotes 6 and 7</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="sost.TF.1.1"><p class="no_margin">See <a href="/books/NBK1228/#sost.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="sost.TF.1.2"><p class="no_margin">See <a href="#sost.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="sost.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="sost.TF.1.4"><p class="no_margin">All pathogenic variants associated with <i>SOST</i>-related sclerosteosis in 94/96 cases are detectable by sequencing [<a class="bk_pop" href="#sost.REF.van_lierop.2017.51">van Lierop et al 2017</a>]. Note that 66/96 reported cases are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the c.69C&#x0003e;T (p.Gln24Ter) South African <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a>. See footnote 6 regarding the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> associated with van Buchem disease.</p></div></dd><dt>5. </dt><dd><div id="sost.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="sost.TF.1.6"><p class="no_margin">A <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> 52-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> downstream of <i>SOST</i>, which does not overlap the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a>, has been described in all Dutch individuals with van Buchem disease [<a class="bk_pop" href="#sost.REF.balemans.2002.91">Balemans et al 2002</a>, <a class="bk_pop" href="#sost.REF.staehlinghampton.2002.144">Staehling-Hampton et al 2002</a>].</p></div></dd><dt>7. </dt><dd><div id="sost.TF.1.7"><p class="no_margin">No additional data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div></div></div></div><div id="sost.Clinical_Characteristics"><h2 id="_sost_Clinical_Characteristics_">Clinical Characteristics</h2><div id="sost.Clinical_Description"><h3>Clinical Description</h3><p>Hypothesized to be allelic disorders [<a class="bk_pop" href="#sost.REF.beighton.1984.175">Beighton et al 1984</a>], sclerosteosis and van Buchem disease were confirmed to be caused by pathogenic variants in the same <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in 2002 [<a class="bk_pop" href="#sost.REF.balemans.2002.91">Balemans et al 2002</a>, <a class="bk_pop" href="#sost.REF.staehlinghampton.2002.144">Staehling-Hampton et al 2002</a>]. The two disorders have very similar phenotypes caused by genetic deficiency of sclerostin; however, the manifestations of van Buchem disease are generally milder than those in sclerosteosis and syndactyly is absent (<a class="figpopup" href="/books/NBK1228/table/sost.T.distinguishing_features_of_sclero/?report=objectonly" target="object" rid-figpopup="figsostTdistinguishingfeaturesofsclero" rid-ob="figobsostTdistinguishingfeaturesofsclero">Table 2</a>) [<a class="bk_pop" href="#sost.REF.beighton.1995">Beighton 1995</a>]. Taken together, these two disorders are known as <i>SOST</i>-related sclerosing bone dysplasias.</p><div id="sost.Clinical_Features_of_Sclerosteosis"><h4>Clinical Features of Sclerosteosis</h4><p><b>Syndactyly,</b> ranging from soft-tissue webbing to bony union of the phalanges, is found at birth in 66% of individuals. It most often affects the second and third fingers, although other fingers or toes can be affected as well.</p><p>More subtle deformity of the digits can also be seen, such as radial deviation of the phalanges or nail aplasia [<a class="bk_pop" href="#sost.REF.itin.2001.259">Itin et al 2001</a>].</p><p><b>Facial distortion</b> due to bossing of the forehead and mandibular overgrowth is seen in 90% of individuals, with proptosis, hypertelorism, or midfacial hypoplasia found in some. These facial findings become apparent in early childhood and progress into adulthood [<a class="bk_pop" href="#sost.REF.hamersma.2003.192">Hamersma et al 2003</a>, <a class="bk_pop" href="#sost.REF.van_lierop.2017.51">van Lierop et al 2017</a>].</p><p><b>Tall stature</b> appears at school age. Longitudinal growth arrests at puberty, by which time individuals can reach heights exceeding two meters (6.5 feet).</p><p><b>Recurrent facial palsies</b> are hallmark complications in sclerosteosis, affecting 93% of individuals. The first episodes develop in early childhood and in some cases within the first months of life. The palsies are caused by narrowing of the neural foramina due to bone overgrowth of the skull.</p><p>Other, less common nerve entrapment syndromes in sclerosteosis are visual loss (2nd cranial nerve), neuralgia or anosmia (5th cranial nerve), and sensory hearing loss (8th cranial nerve) [<a class="bk_pop" href="#sost.REF.van_lierop.2017.51">van Lierop et al 2017</a>].</p><p><b>Hearing loss</b> is also highly prevalent, affecting 94% of individuals. It starts as conductive hearing loss in childhood, but often progresses into mixed conductive, sensorineural hearing loss later in life [<a class="bk_pop" href="#sost.REF.hamersma.2003.192">Hamersma et al 2003</a>, <a class="bk_pop" href="#sost.REF.van_lierop.2017.51">van Lierop et al 2017</a>].</p><p><b>Increased intracranial pressure</b> can develop due to narrowing of the intracranial cavity by the thickening of calvaria. It often starts in late adolescence. In a recent study, it was reported in 71% of individuals with sclerosteosis, and was considered the cause of death in 12 out of 33 deceased individuals of Afrikaner background, while six additional individuals died due to perioperative complications [<a class="bk_pop" href="#sost.REF.van_lierop.2017.51">van Lierop et al 2017</a>].</p><p><b>Clinical course of the disease.</b> While syndactyly is the only symptom of sclerosteosis present at birth, other symptoms develop early in childhood. The disease progresses into adulthood but appears to stabilize in the third decade in the majority of those with sclerosteosis [<a class="bk_pop" href="#sost.REF.van_lierop.2011.2804">van Lierop et al 2011</a>, <a class="bk_pop" href="#sost.REF.van_lierop.2013.848">van Lierop et al 2013</a>].</p></div><div id="sost.Clinical_Features_of_van_Buchem_Dis"><h4>Clinical Features of van Buchem Disease</h4><p>All of the above features can be found, except for syndactyly.</p><p>Overall there is a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> than observed in sclerosteosis. For example, increased intracranial pressure is rare in individuals with van Buchem disease [<a class="bk_pop" href="#sost.REF.van_lierop.2010.2796">van Lierop et al 2010</a>, <a class="bk_pop" href="#sost.REF.van_lierop.2013.848">van Lierop et al 2013</a>].</p><p>Van Buchem disease also tends to stabilize in adulthood [<a class="bk_pop" href="#sost.REF.van_lierop.2013.848">van Lierop et al 2013</a>].</p><div id="sost.T.distinguishing_features_of_sclero" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Distinguishing Features of Sclerosteosis and van Buchem Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1228/table/sost.T.distinguishing_features_of_sclero/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sost.T.distinguishing_features_of_sclero_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></th><th id="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sclerosteosis</th><th id="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">van Buchem Disease</th></tr></thead><tbody><tr><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Reported cases</b></td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">96</td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">31</td></tr><tr><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Prognosis</b></td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Potentially lethal</td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comparatively benign</td></tr><tr><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Habitus</b></td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gigantism</td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal stature</td></tr><tr><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Facies</b></td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gross distortion</td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Prominent mandible</td></tr><tr><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Teeth</b></td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Malaligned, w/malocclusion</td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td></tr><tr><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cranial nerve palsy</b></td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Very common</td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Common</td></tr><tr><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Intracranial pressure</b></td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Raised</td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Inconsistent elevation</td></tr><tr><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Syndactyly</b></td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequent</td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent</td></tr><tr><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Nail hypoplasia</b></td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequent</td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Absent</td></tr><tr><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cranial hyperostosis</b></td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gross</td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Moderate</td></tr><tr><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Distortion of tubular bones of hands &#x00026; feet</b></td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Marked</td><td headers="hd_h_sost.T.distinguishing_features_of_sclero_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Modified from <a class="bk_pop" href="#sost.REF.beighton.1995">Beighton [1995]</a>, p 234</p></div></dd></dl></div></div></div></div><div id="sost.Laboratory_Tests"><h4>Laboratory Tests</h4><p><b>Sclerostin.</b> Serum levels of sclerostin are undetectable in sclerosteosis [<a class="bk_pop" href="#sost.REF.van_lierop.2011.2804">van Lierop et al 2011</a>], but low levels can be detected in patients with van Buchem disease [<a class="bk_pop" href="#sost.REF.van_lierop.2013.848">van Lierop et al 2013</a>].</p><p><b>Bone formation markers.</b> Levels of bone formation markers, such as procollagen type 1 aminoterminal propeptide (P1NP), alkaline phosphatase, or osteocalcin, are elevated in both sclerosteosis and van Buchem disease. Levels decline with age but remain elevated above the upper limit of normal in the majority of individuals [<a class="bk_pop" href="#sost.REF.wergedal.2003.5778">Wergedal et al 2003</a>, <a class="bk_pop" href="#sost.REF.van_lierop.2011.2804">van Lierop et al 2011</a>, <a class="bk_pop" href="#sost.REF.van_lierop.2013.848">van Lierop et al 2013</a>].</p><p><b>Bone resorption markers.</b> Levels of the bone resorption marker serum collagen type 1 cross-linked C-telopeptide (sCTX) are increased in childhood, but levels decrease with age toward the lower end of the reference range in adulthood [<a class="bk_pop" href="#sost.REF.van_lierop.2011.2804">van Lierop et al 2011</a>, <a class="bk_pop" href="#sost.REF.van_lierop.2013.848">van Lierop et al 2013</a>]. Urinary cross-linker N-telopeptide (uNTX) was elevated in six individuals with van Buchem disease [<a class="bk_pop" href="#sost.REF.wergedal.2003.5778">Wergedal et al 2003</a>].</p><p><b>Normal findings.</b> Serum concentrations of calcium and phosphorus and levels of parathyroid hormone are normal [<a class="bk_pop" href="#sost.REF.epstein.1979.1105">Epstein et al 1979</a>, <a class="bk_pop" href="#sost.REF.van_lierop.2011.2804">van Lierop et al 2011</a>].</p></div><div id="sost.Bone_Findings"><h4>Bone Findings</h4><p>Bone mineral density measured by DXA is greatly increased with Z-scores ranging from +7.7 to +14.4 at the spine and +7.8 to +11.5 at the hip in individuals with sclerosteosis [<a class="bk_pop" href="#sost.REF.balemans.2005.943">Balemans et al 2005</a>, <a class="bk_pop" href="#sost.REF.piters.2010.e1526">Piters et al 2010</a>, <a class="bk_pop" href="#sost.REF.power.2010.1867">Power et al 2010</a>, <a class="bk_pop" href="#sost.REF.van_lierop.2011.2804">van Lierop et al 2011</a>], and from +5.4 to +12.3 at the spine and +5.2 to +12.1 at the hip, in individuals with van Buchem disease [<a class="bk_pop" href="#sost.REF.van_lierop.2013.848">van Lierop et al 2013</a>].</p><p>Histologic examination of bone reveals increased bone volume and thickness of cortex and trabeculae, increased osteoblastic bone formation with normal or decreased osteoclastic bone resorption, and no abnormal mineralization of bone tissue [<a class="bk_pop" href="#sost.REF.stein.1983.267">Stein et al 1983</a>, <a class="bk_pop" href="#sost.REF.van_lierop.2017.51">van Lierop et al 2017</a>, <a class="bk_pop" href="#sost.REF.hassler.2014.2144">Hassler et al 2014</a>].</p><p>The high bone density in sclerosteosis is not associated with increased mineralization [<a class="bk_pop" href="#sost.REF.hassler.2014.2144">Hassler et al 2014</a>], as is seen in osteopetrosis, but there is an increased biomechanical competence of the bone and resistance to fractures [<a class="bk_pop" href="#sost.REF.van_lierop.2017.51">van Lierop et al 2017</a>].</p><p>The risk for fractures, osteomyelitis, or bone marrow failure is not increased.</p></div><div id="sost.Life_Expectancy"><h4>Life Expectancy</h4><p>Survival into old age is unusual in <b>sclerosteosis</b> but not unprecedented [<a class="bk_pop" href="#sost.REF.barnard.1980.401">Barnard et al 1980</a>, <a class="bk_pop" href="#sost.REF.van_lierop.2011.2804">van Lierop et al 2011</a>, <a class="bk_pop" href="#sost.REF.van_lierop.2013.848">van Lierop et al 2013</a>]. Life expectancy is reduced because of sudden deaths due to herniation of the brain stem, or perioperative complications from surgery to correct increased intracranial pressure. Mean age of death is 33 years [<a class="bk_pop" href="#sost.REF.hamersma.2003.192">Hamersma et al 2003</a>], but with increasing use of early craniectomy, longer-term survival is likely. The natural history of sclerosteosis has been reviewed in <a class="bk_pop" href="#sost.REF.beighton.1988.200">Beighton [1988]</a>, <a class="bk_pop" href="#sost.REF.beighton.1995">Beighton [1995]</a>, <a class="bk_pop" href="#sost.REF.hamersma.2003.192">Hamersma et al [2003]</a>, and <a class="bk_pop" href="#sost.REF.van_lierop.2017.51">van Lierop et al [2017]</a>.</p><p>Life expectancy in <b>van Buchem disease</b> appears to be normal and individuals have had no significant comorbidities. Sudden death due to herniation of the brain stem has never been reported in patients with van Buchem disease. The oldest individual to be studied was 81 years old with type 2 diabetes mellitus, mild heart failure, and non-metastasized prostate cancer, comorbidities frequent in elderly populations [<a class="bk_pop" href="#sost.REF.van_lierop.2017.51">van Lierop et al 2017</a>].</p></div></div><div id="sost.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>There is no apparent difference in <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> associated with any of the known <i>SOST</i> pathogenic variants. The phenotype of van Buchem disease, which is not caused by pathogenic variants in <i>SOST</i> itself but by a 52-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> downstream of <i>SOST</i>, is milder than that of sclerosteosis.</p></div><div id="sost.Nomenclature"><h3>Nomenclature</h3><p>In the past, sclerosteosis and van Buchem disease have been grouped with other dense bone disorders under nonspecific general terms including "marble bones," "osteopetrosis," and "Albers-Sch&#x000f6;nberg disease." Diagnostic precision and <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> delineation followed, and the term "sclerosteosis" became established. Similarly, van Buchem and his colleagues employed the designation "hyperostosis corticalis generalisata familiaris" for the condition that is now known as "van Buchem disease."</p><p>In the nosology of the dense bone disorders, sclerosteosis and van Buchem disease have been categorized as "craniotubular hyperostoses." With the elucidation of the molecular basis of these conditions, they are now classified together as <i>SOST</i>-related sclerosing bone dysplasias.</p></div><div id="sost.Prevalence"><h3>Prevalence</h3><p>Sclerosteosis is primarily found among the Afrikaner (Dutch ancestry) community of South Africa, where the <a class="def" href="/books/n/gene/glossary/def-item/carrier-rate/">carrier rate</a> is estimated at 1:100 and prevalence at 1: 60.000 [<a class="bk_pop" href="#sost.REF.beighton.1979.783">Beighton &#x00026; Hamersma 1979</a>]. However, cases outside the Afrikaner population have been reported [<a class="bk_pop" href="#sost.REF.van_lierop.2017.51">van Lierop et al 2017</a>]. With 96 cases reported worldwide up to 2017, of which 66 were from South Africa, sclerosteosis is an extremely rare disease outside South Africa.</p><p>There have been only 31 reported cases of van Buchem disease, of which 29 were from the Netherlands and two were from Germany [<a class="bk_pop" href="#sost.REF.van_lierop.2017.51">van Lierop et al 2017</a>].</p></div></div><div id="sost.Genetically_Related_Allelic_Disorde"><h2 id="_sost_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p><b>Craniodiaphyseal dysplasia (CDD).</b> In the <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> form of CDD (OMIM <a href="http://omim.org/entry/122860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">122860</a>) <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>SOST</i> pathogenic variants have been documented in two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children in Korea and Poland [<a class="bk_pop" href="#sost.REF.kim.2011.497">Kim et al 2011</a>]. Details of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in the latter child had been published previously [<a class="bk_pop" href="#sost.REF.bieganski.2007.2435">Bieganski et al 2007</a>]. The main phenotypic features are progressive overgrowth of the craniofacial bones with deafness, facial palsy, and visual disturbance as a result of nerve entrapment. Choanal stenosis is a clinically significant complication. Radiologically the cranial and facial bones are hyperostotic while the diaphyses of the limb bones are expanded with thin cortices. In CDD, <i>SOST</i> pathogenic variants are located in the secretion signal of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and prevent sclerostin secretion possibly by a dominant negative mechanism [<a class="bk_pop" href="#sost.REF.kim.2011.497">Kim et al 2011</a>]. Since this report no other cases have been published.</p></div><div id="sost.Differential_Diagnosis"><h2 id="_sost_Differential_Diagnosis_">Differential Diagnosis</h2><p><i>SOST</i>-related sclerosing bone dysplasia is included in the category of craniotubular hyperostoses, which need to be distinguished from other sclerosing bone dysplasias. These include:</p><ul><li class="half_rhythm"><div>The osteoscleroses, notably osteopetrosis, characterized by increased bone density with no bone overgrowth and little or no disturbance of the contours of the bones; and</div></li><li class="half_rhythm"><div>The craniotubular dysplasias, characterized by abnormal modeling of the skeleton and moderate sclerosis of the calvarium and base of the skull.</div></li></ul><p>The predominant feature of the craniotubular hyperostoses is overgrowth of bone, which leads to alterations of contours and increase in radiologic density of the skeleton. The bones are often very resistant to trauma. In addition to <i>SOST</i>-related sclerosing bone dysplasia, this group of disorders includes the conditions summarized in <a class="figpopup" href="/books/NBK1228/table/sost.T.other_craniotubular_hyperostoses/?report=objectonly" target="object" rid-figpopup="figsostTothercraniotubularhyperostoses" rid-ob="figobsostTothercraniotubularhyperostoses">Table 3</a>.</p><div id="sost.T.other_craniotubular_hyperostoses" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Other Craniotubular Hyperostoses to Consider in the Differential Diagnosis of <i>SOST</i>-Related Sclerosing Bone Dysplasias</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1228/table/sost.T.other_craniotubular_hyperostoses/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sost.T.other_craniotubular_hyperostoses_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features</th></tr><tr><th headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_4" id="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/<i>SOST</i>-related sclerosing bone dysplasias</th><th headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_4" id="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from <i>SOST</i>-related sclerosing bone dysplasias</th></tr></thead><tbody><tr><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Endosteal hyperostosis, Worth form (OMIM <a href="http://omim.org/entry/144750" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">144750</a>)</td><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LRP5</i></td><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_4 hd_h_sost.T.other_craniotubular_hyperostoses_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hyperostosis of long bones &#x00026; skull</div></li><li class="half_rhythm"><div>Cranial nerve impingement &#x00026; hearing loss</div></li><li class="half_rhythm"><div>Enlargement of the mandible</div></li></ul>
</td><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_4 hd_h_sost.T.other_craniotubular_hyperostoses_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Smooth or bony swellings may be on the palate (taurus palatinum).</div></li><li class="half_rhythm"><div>Milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></div></li><li class="half_rhythm"><div>Normal height</div></li><li class="half_rhythm"><div>No syndactyly</div></li></ul>
</td></tr><tr><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ced/">Camurati-Engelmann disease</a> (CED; progressive diaphyseal dysplasia)</td><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TGFB1</i>&#x000a0;<sup>1</sup></td><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_4 hd_h_sost.T.other_craniotubular_hyperostoses_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hyperostosis of long bones, skull may be affected</div></li><li class="half_rhythm"><div>Frontal bossing, enlargement of mandible &#x00026; proptosis, &#x00026; cranial nerve impingement resulting in facial palsy seen in severe cases later in life</div></li></ul>
</td><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_4 hd_h_sost.T.other_craniotubular_hyperostoses_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Proximal muscle weakness</div></li><li class="half_rhythm"><div>Severe limb pain</div></li><li class="half_rhythm"><div>Joint contractures</div></li><li class="half_rhythm"><div>No syndactyly</div></li></ul>
</td></tr><tr><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Craniodiaphyseal dysplasia (CDD)<br />(OMIM <a href="http://omim.org/entry/122860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">122860</a>)</td><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Footnote 2</td><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_4 hd_h_sost.T.other_craniotubular_hyperostoses_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hyperostosis of skull</div></li><li class="half_rhythm"><div>Facial deformity w/hypertelorism</div></li><li class="half_rhythm"><div>Cranial nerve impingement &#x00026; hearing loss</div></li></ul>
</td><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_4 hd_h_sost.T.other_craniotubular_hyperostoses_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Severe progressive sclerosing bone dysplasia w/maximal involvement of the craniofacial skeleton</div><div>Long bones, ribs, &#x00026; pelvis less affected</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>No syndactyly</div></li></ul>
</td></tr><tr><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sclerosteosis-like <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (sclerosteosis 2)<br />(OMIM <a href="http://omim.org/entry/614305" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614305</a>)</td><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LRP4</i></td><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR</td><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_4 hd_h_sost.T.other_craniotubular_hyperostoses_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hyperostosis of long bones &#x00026; skull</div></li><li class="half_rhythm"><div>Facial deformity</div></li><li class="half_rhythm"><div>Cranial nerve impingement &#x00026; hearing loss</div></li><li class="half_rhythm"><div>Tall stature</div></li></ul>
</td><td headers="hd_h_sost.T.other_craniotubular_hyperostoses_1_1_1_4 hd_h_sost.T.other_craniotubular_hyperostoses_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal or increased serum sclerostin levels</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="sost.TF.3.1"><p class="no_margin">Diagnosis of CED is based on physical examination and radiographic findings and can be confirmed by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Bone and muscle histology are nonspecific. <i>TGFB1</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which mutation is known to cause CED. Sequence analysis identifies pathogenic variants in <i>TGFB1</i> in about 90% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div></dd><dt>2. </dt><dd><div id="sost.TF.3.2"><p class="no_margin">CDD is possibly heterogeneous. Heterozygous pathogenic variants in <i>SOST</i> have been demonstrated in two unrelated <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children [<a class="bk_pop" href="#sost.REF.kim.2011.497">Kim et al 2011</a>] (see <a href="#sost.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</a>).</p></div></dd></dl></div></div></div></div><div id="sost.Management"><h2 id="_sost_Management_">Management</h2><div id="sost.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with a <i>SOST</i>-related sclerosing bone dysplasia, the evaluations summarized in <a class="figpopup" href="/books/NBK1228/table/sost.T.recommended_evaluations_following/?report=objectonly" target="object" rid-figpopup="figsostTrecommendedevaluationsfollowing" rid-ob="figobsostTrecommendedevaluationsfollowing">Table 4</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><div id="sost.T.recommended_evaluations_following" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with <i>SOST</i>-Related Sclerosing Bone Dysplasia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1228/table/sost.T.recommended_evaluations_following/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sost.T.recommended_evaluations_following_lrgtbl__"><table><thead><tr><th id="hd_h_sost.T.recommended_evaluations_following_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_sost.T.recommended_evaluations_following_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th></tr></thead><tbody><tr><td headers="hd_h_sost.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Skeletal</b></td><td headers="hd_h_sost.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Radiographic &#x00026; imaging studies incl bone densitometry</div></li><li class="half_rhythm"><div>Assessment of necessity for surgical correction of syndactyly when present</div></li></ul>
</td></tr><tr><td headers="hd_h_sost.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_sost.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic evaluation for consequences of cranial nerve entrapment</td></tr><tr><td headers="hd_h_sost.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ophthalmologic</b></td><td headers="hd_h_sost.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation for evidence of increased intracranial pressure &#x00026;/or proptosis</td></tr><tr><td headers="hd_h_sost.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing</b></td><td headers="hd_h_sost.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Formal audiologic evaluation</td></tr><tr><td headers="hd_h_sost.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_sost.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td></tr></tbody></table></div></div></div><div id="sost.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>No specific treatment for sclerosteosis or van Buchem disease is currently available, and management aims at relieving symptoms and preventing complications. Treatment of these disorders therefore mainly consists of surgical intervention to ameliorate complications.</p><p>In one adult case of severe van Buchem disease, treatment with glucocorticoids was successful in suppressing bone formation and disease progression [<a class="bk_pop" href="#sost.REF.van_lierop.2010.2796">van Lierop et al 2010</a>], although the individual still needed repeated surgery [<a class="bk_pop" href="#sost.REF.datema.2015.1215">Datema et al 2015</a>]. In two children with van Buchem disease short courses of prednisolone were given during exacerbations of facial palsies. While biochemical bone turnover markers decreased during therapy, there was no clinical improvement of steroid treatment in these cases [<a class="bk_pop" href="#sost.REF.van_egmond.2012.740">van Egmond et al 2012</a>] The long-term benefits of this treatment in sclerosteosis or van Buchem disease have not been studied.</p><p>Important note: The bones in sclerosteosis are thick and dense; surgical intervention may be difficult and prolonged. Standard neurosurgical instruments may not be sufficient (i.e., drill bits may be too short and power tools may be damaged by the dense bone) [<a class="bk_pop" href="#sost.REF.du_plessis.1993.388">du Plessis 1993</a>]. In addition, bone regrowth occurs and may cause recurrence of symptoms.</p><div id="sost.T.treatment_of_manifestations_in_in" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with <i>SOST</i>-Related Sclerosing Bone Dysplasia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1228/table/sost.T.treatment_of_manifestations_in_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sost.T.treatment_of_manifestations_in_in_lrgtbl__"><table><thead><tr><th id="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/Concern</th><th id="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Syndactyly</b></td><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Surgical correction</td><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May be necessary in early childhood to improve function &#x00026; cosmetic appearance</td></tr><tr><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Entrapped cranial nerves that can cause recurrent facial paralysis similar to Bell's palsy or facial pain</b></td><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Surgical decompression</td><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">From age 2 yrs onwards</td></tr><tr><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Elevated intracranial pressure</b></td><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Craniectomy</div></li><li class="half_rhythm"><div>Ventriculo-peritoneal drain</div></li></ul>
</td><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>From age 5 yrs onwards but usually in young adulthood</div></li><li class="half_rhythm"><div>In South Africa this procedure is undertaken at an increasingly young age.</div></li></ul>
</td></tr><tr><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Mandibular overgrowth</b></td><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Surgical reduction</td><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>May be performed for cosmetic reasons or if mouth closure is impaired due to mandible overgrowth</div></li><li class="half_rhythm"><div>Tooth extraction may be difficult.</div></li><li class="half_rhythm"><div>Management by an orthodontic or craniofacial team is recommended.</div></li></ul>
</td></tr><tr><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing loss</b></td><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hearing aids</div></li><li class="half_rhythm"><div>Middle-ear surgery for conductive loss</div></li><li class="half_rhythm"><div>Cochlear implant if obliteration of the internal auricular canal &#x00026; damage to auditory nerve</div></li></ul>
</td><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Radiculopathy</b></td><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spinal cord decompression</td><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In adulthood</td></tr><tr><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Proptosis &#x00026; glaucoma</b></td><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Orbital decompression</td><td headers="hd_h_sost.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In adulthood</td></tr></tbody></table></div></div></div><div id="sost.Surveillance"><h3>Surveillance</h3><div id="sost.T.recommended_surveillance_for_indi" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with <i>SOST</i>-Related Sclerosing Bone Dysplasia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1228/table/sost.T.recommended_surveillance_for_indi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sost.T.recommended_surveillance_for_indi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Bone mass</b></td><td headers="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bone mineral density measurement &#x00026; biochemical markers of bone turnover</td><td headers="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually at pediatric age, biennially at adult age</td></tr><tr><td headers="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Examination for consequences of cranial nerve entrapment</td><td headers="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 6 mos at pediatric age, annually at adult age</td></tr><tr><td headers="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ophthalmologic</b></td><td headers="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proptosis, eye pressure, &#x00026; evaluation of the optic nerve papilla</td><td headers="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr><tr><td headers="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing</b></td><td headers="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Audiologic assessment</td><td headers="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr><tr><td headers="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Teeth</b></td><td headers="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dental &#x00026; orthodontic evaluation of tooth malalignment &#x00026; malocclusion</td><td headers="hd_h_sost.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually at pediatric age, routine dental care at adult age</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="sost.TF.6.1"><p class="no_margin">Note: Since no published guidelines are available, all suggested intervals are at the discretion of the treating physician.</p></div></dd></dl></div></div></div></div><div id="sost.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Agents known to suppress bone resorption:</p><ul><li class="half_rhythm"><div>Bisphosphonates</div></li><li class="half_rhythm"><div>Denosumab</div></li><li class="half_rhythm"><div>Selective estrogen receptor modulators (SERMS)</div></li></ul><p>Agents known to stimulate bone formation:</p><ul><li class="half_rhythm"><div>Teriparatide</div></li><li class="half_rhythm"><div>Abaloparatide</div></li><li class="half_rhythm"><div>Romozosumab</div></li></ul></div><div id="sost.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#sost.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="sost.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="sost.Genetic_Counseling"><h2 id="_sost_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="sost.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>SOST</i>-related sclerosing bone dysplasias are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="sost.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (carriers of one <i>SOST</i>-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes have increased bone mass and calvarial widening, but signs or symptoms of the disease have not been described.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a 25% chance of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes have increased bone mass and calvarial widening, but signs or symptoms of the disease have not been described.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The offspring of an individual with <i>SOST</i>-related sclerosing bone dysplasia are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SOST</i>.</div></li><li class="half_rhythm"><div>If the reproductive partner of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>SOST</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, each offspring has a 50% chance of inheriting two copies of an <i>SOST</i> pathogenic variant and being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. Reproductive partners are more likely to be carriers of an <i>SOST</i> pathogenic variant if they are related to the proband or are members of populations with a high <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency (e.g., the Afrikaner community in South Africa). See <a href="#sost.Prevalence">Prevalence</a>.</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>SOST</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="sost.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk family members requires prior identification of the pathogenic variants in the family.</p></div><div id="sost.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#sost.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="sost.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>SOST</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p><b>Ultrasound examination</b> may be able to detect syndactyly in fetuses at risk for sclerosteosis. This finding is variable in sclerosteosis and therefore its presence in an at-risk fetus is indicative of sclerosteosis, but its absence is not indicative of an unaffected fetus.</p></div></div><div id="sost.Resources"><h2 id="_sost_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Society for Deaf Children (ASDC)</b></div><div>800 Florida Avenue Northeast</div><div>Suite 2047</div><div>Washington DC 20002-3695</div><div><b>Phone:</b> 800-942-2732 (Toll-free Parent Hotline); 866-895-4206 (toll free voice/TTY)</div><div><b>Fax:</b> 410-795-0965</div><div><b>Email:</b> info@deafchildren.org; asdc@deafchildren.org</div><div><a href="http://www.deafchildren.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.deafchildren.org</a></div></li><li class="half_rhythm"><div><b>Face Equality International</b></div><div>United Kingdom</div><div><b>Email:</b> info@faceequalityinternational.org</div><div><a href="https://faceequalityinternational.org/thealliance/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.faceequalityinternational.org</a></div></li><li class="half_rhythm"><div><b>National Association of the Deaf (NAD)</b></div><div>8630 Fenton Street</div><div>Suite 820</div><div>Silver Spring MD 20910</div><div><b>Phone:</b> 301-587-1788; 301-587-1789 (TTY)</div><div><b>Fax:</b> 301-587-1791</div><div><b>Email:</b> nad.info@nad.org</div><div><a href="http://www.nad.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nad.org</a></div></li></ul></div><div id="sost.Molecular_Genetics"><h2 id="_sost_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="sost.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>SOST-Related Sclerosing Bone Dysplasias: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1228/table/sost.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sost.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_sost.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_sost.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_sost.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_sost.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_sost.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_sost.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_sost.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/50964" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SOST</i></a></td><td headers="hd_b_sost.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=50964" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17q21<wbr style="display:inline-block"></wbr>​.31</a></td><td headers="hd_b_sost.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9BQB4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Sclerostin</a></td><td headers="hd_b_sost.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/SOST" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SOST @ LOVD</a></td><td headers="hd_b_sost.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SOST" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SOST</a></td><td headers="hd_b_sost.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SOST[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SOST</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="sost.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="sost.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for SOST-Related Sclerosing Bone Dysplasias (<a href="/omim/239100,269500,605740" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1228/table/sost.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sost.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/239100" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">239100</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">VAN BUCHEM DISEASE; VBCH</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/269500" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">269500</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SCLEROSTEOSIS 1; SOST1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605740" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605740</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SCLEROSTIN; SOST</td></tr></tbody></table></div></div><div id="sost.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><i>SOST</i> encodes for the 190-residue glycoprotein sclerostin, which is predominantly secreted by osteocytes. Sclerostin acts as an inhibitor of bone formation through suppressing the canonic Wnt signaling pathway in cells of the osteoblast lineage. Sclerostin binds to the Wnt-signaling coreceptors LRP5 and LRP6, thereby disabling the binding of Wnt particles to these receptors. For this mode of action sclerostin is reliant on its own coreceptor, LRP4.</p><p><b>Mechanism of disease causation: loss of function</b></p><ul><li class="half_rhythm"><div>Sclerosteosis, caused by loss of sclerostin expression, results in bone formation being less restrained, resulting in progressive generalized hyperostosis.</div></li><li class="half_rhythm"><div>Individuals with van Buchem disease, caused by a large <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of regulatory elements only necessary for postnatal SOST transcription downstream of <i>SOST</i>, do not develop syndactyly.</div></li></ul><div id="sost.T.notable_sost_pathogenic_variants" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p>Notable <i>SOST</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1228/table/sost.T.notable_sost_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sost.T.notable_sost_pathogenic_variants_lrgtbl__"><table><thead><tr><th id="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th><th id="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment [Reference]</th></tr></thead><tbody><tr><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_1" rowspan="11" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_025237.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_025237<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_079513.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_079513<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.69C&#x0003e;T</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln24Ter</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Founder variant in South Africa [<a class="bk_pop" href="#sost.REF.brunkow.2001.577">Brunkow et al 2001</a>]</td></tr><tr><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.79C&#x0003e;T</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln27Ter</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Observed <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> in an individual from Morocco [<a class="bk_pop" href="#sost.REF.belkhribchia.2014.133">Belkhribchia et al 2014</a>]</td></tr><tr><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.87dupC</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys30GInfsTer3</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Observed <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> in individuals in Egypt [<a class="bk_pop" href="#sost.REF.fayez.2015.517815">Fayez et al 2015</a>]</td></tr><tr><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.220+1G&#x0003e;C</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Observed <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> in individuals in Germany [<a class="bk_pop" href="#sost.REF.kim.2008.475">Kim et al 2008</a>]</td></tr><tr><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.220+3A&#x0003e;T</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Observed <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> in an individual from Senegal [<a class="bk_pop" href="#sost.REF.balemans.2001.537">Balemans et al 2001</a>]</td></tr><tr><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.296dupC</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p. Val100fsTer128</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Observed <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> in an individual from India [<a class="bk_pop" href="#sost.REF.bhadada.2013.707">Bhadada et al 2013</a>]</td></tr><tr><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.371G&#x0003e;A</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">pTrp124Ter</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Observed <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> in an individual from Turkey [<a class="bk_pop" href="#sost.REF.yagi.2015.1239">Yagi et al 2015</a>]</td></tr><tr><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.372G&#x0003e;A</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp124Ter</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Founder variant in Brazil [<a class="bk_pop" href="#sost.REF.balemans.2001.537">Balemans et al 2001</a>, <a class="bk_pop" href="#sost.REF.kim.2008.475">Kim et al 2008</a>]</td></tr><tr><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.376C&#x0003e;T</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg126Ter</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Founder variant in US (one kindred of mixed ancestry from Maryland) [<a class="bk_pop" href="#sost.REF.balemans.2001.537">Balemans et al 2001</a>]</td></tr><tr><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.444_445delinsAA</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys148Ter</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Observed <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> in an individual from China [<a class="bk_pop" href="#sost.REF.he.2016.205">He et al 2016</a>]</td></tr><tr><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.449T&#x0003e;C</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys167Arg</td><td headers="hd_h_sost.T.notable_sost_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Founder variant in Turkey [<a class="bk_pop" href="#sost.REF.piters.2010.e1526">Piters et al 2010</a>]</td></tr></tbody></table></div></div></div></div><div id="sost.References"><h2 id="_sost_References_">References</h2><div id="sost.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="sost.REF.balemans.2005.943">Balemans W, Cleiren E, Siebers U, Horst J, Van Hul W. A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene. <span><span class="ref-journal">Bone. </span>2005;<span class="ref-vol">36</span>:943–7.</span> [<a href="/pubmed/15869924" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15869924</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.balemans.2001.537">Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). <span><span class="ref-journal">Hum Mol Genet. </span>2001;<span class="ref-vol">10</span>:537–43.</span> [<a href="/pubmed/11181578" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11181578</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.balemans.2002.91">Balemans W, Patel N, Ebeling M, Van Hul E, Wuyts W, Lacza C, Dioszegi M, Dikkers FG, Hildering P, Willems PJ, Verheij JB, Lindpaintner K, Vickery B, Foernzler D, Van Hul W. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:91–7.</span> [<a href="/pmc/articles/PMC1735035/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735035</span></a>] [<a href="/pubmed/11836356" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11836356</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.barnard.1980.401">Barnard AH, Hamersma H, Kretzmar JH, Beighton P. Sclerosteosis in old age. <span><span class="ref-journal">S Afr Med J. </span>1980;<span class="ref-vol">58</span>:401–3.</span> [<a href="/pubmed/7404164" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7404164</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.beighton.1988.200">Beighton P. Sclerosteosis. <span><span class="ref-journal">J Med Genet. </span>1988;<span class="ref-vol">25</span>:200–3.</span> [<a href="/pmc/articles/PMC1015488/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1015488</span></a>] [<a href="/pubmed/3351908" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3351908</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.beighton.1995">Beighton P. Sclerosteosis. In: Donnai D, Winter RM, eds. <em>Congenital Malformation Syndromes</em>. London, UK: Chapman and Hall Medical Books Ltd; 1995:230-5.</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.beighton.1984.175">Beighton P, Barnard A, Hamersma H, van der Wouden A. The syndromic status of sclerosteosis and van Buchem disease. <span><span class="ref-journal">Clin Genet. </span>1984;<span class="ref-vol">25</span>:175–81.</span> [<a href="/pubmed/6323069" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6323069</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.beighton.1979.783">Beighton P, Hamersma H. Sclerosteosis in South Africa. <span><span class="ref-journal">S Afr Med J. </span>1979;<span class="ref-vol">55</span>:783–8.</span> [<a href="/pubmed/223247" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 223247</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.belkhribchia.2014.133">Belkhribchia MR, Collet C, Laplanche JL, Hassani R. Novel SOST gene mutation in a sclerosteosis patient from Marocco: a case report. <span><span class="ref-journal">Eur. J. Med. Genet. </span>2014;<span class="ref-vol">57</span>:133–7.</span> [<a href="/pubmed/24594238" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24594238</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.bieganski.2007.2435">Bieganski T, Baranska D, Miastkowska I, Kobielski A, Gorska-Chrzastek M, Kozlowski K. A boy with severe craniodiaphyseal dysplasia and apparently normal mother. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:2435–43.</span> [<a href="/pubmed/17853455" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17853455</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.bhadada.2013.707">Bhadada SK, Rastogi A, Steenackers E, Boudin E, Arya A, Dhiman V, Bhansali A, Van Hul W. Novel SOST gene mutation in a sclerosteosis patient and her parents. <span><span class="ref-journal">Bone. </span>2013;<span class="ref-vol">52</span>:707–10.</span> [<a href="/pubmed/23079137" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23079137</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.brunkow.2001.577">Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu Y, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan J. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">68</span>:577–89.</span> [<a href="/pmc/articles/PMC1274471/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1274471</span></a>] [<a href="/pubmed/11179006" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11179006</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.datema.2015.1215">Datema M, Appelman-Dijkstra NM, Hoyng SA, Verstegen MJ, Koot RW. Decompressive surgery in a patient with hyperostosis corticalis generalisata for relief of cognitive disability and dysaesthesia. <span><span class="ref-journal">Acta Neurochir (Wien). </span>2015;<span class="ref-vol">157</span>:1215–8.</span> [<a href="/pubmed/25976340" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25976340</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.du_plessis.1993.388">du Plessis JJ. Sclerosteosis: neurosurgical experience with 14 cases. <span><span class="ref-journal">J Neurosurg. </span>1993;<span class="ref-vol">78</span>:388–92.</span> [<a href="/pubmed/8433139" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8433139</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.epstein.1979.1105">Epstein S, Hamersma H, Beighton P. Endocrine function in sclerosteosis. <span><span class="ref-journal">S Afr Med J. </span>1979;<span class="ref-vol">55</span>:1105–10.</span> [<a href="/pubmed/225834" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 225834</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.fayez.2015.517815">Fayez A, Aglan M, Esmaiel N, El Zanaty T, Abdel Kader M, El Ruby MA. Novel loss of sclerostin function mutation in a first Egyptian family with sclerosteosis. <span><span class="ref-journal">Biomed. Res. Int. </span>2015;<span class="ref-vol">2015</span>:517815.</span> [<a href="/pmc/articles/PMC4423033/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4423033</span></a>] [<a href="/pubmed/25984533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25984533</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.hamersma.2003.192">Hamersma H, Gardner J, Beighton P. The natural history of sclerosteosis. <span><span class="ref-journal">Clin Genet. </span>2003;<span class="ref-vol">63</span>:192–7.</span> [<a href="/pubmed/12694228" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12694228</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.hassler.2014.2144">Hassler N, Roschger A, Gamsjaeger S, Kramer I, Lueger S, van Lierop A, Roschger P, Klaushofer K, Paschalis EP, Kneissel M, Papapoulos S. Sclerostin deficiency is linked to altered bone composition. <span><span class="ref-journal">J Bone Miner Res. </span>2014;<span class="ref-vol">29</span>:2144–51.</span> [<a href="/pubmed/24753092" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24753092</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.he.2016.205">He WT, Chen C, Pan C, Zhang MX, Yu XF, Wang DW, Hu SW. Sclerosteosis caused by a novel nonsense mutation of SOST in a consanguineous family. <span><span class="ref-journal">Clin Genet. </span>2016;<span class="ref-vol">89</span>:205–9.</span> [<a href="/pubmed/26283468" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26283468</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.itin.2001.259">Itin PH, Keser&#x000fc; B, Hauser V. Syndactyly/brachyphalangy and nail dysplasias as marker lesions for sclerosteosis. <span><span class="ref-journal">Dermatology. </span>2001;<span class="ref-vol">202</span>:259–60.</span> [<a href="/pubmed/11385236" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11385236</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.kim.2008.475">Kim CA, Honjo R, Bertola D, Albano L, Oliveira L, Jales S, Siqueira J, Castilho A, Balemans W, Piters E, Jennes K, Van Hul W. A known SOST gene mutation causes sclerosteosis in a familial and an isolated case from Brazilian origin. <span><span class="ref-journal">Genet Test. </span>2008;<span class="ref-vol">12</span>:475–9.</span> [<a href="/pubmed/19072561" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19072561</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.kim.2011.497">Kim SJ, Bieganski T, Sohn YB, Kozlowski K, Sem&#x000eb;nov M, Okamoto N, Kim CH, Ko AR, Ahn GH, Choi YL, Park SW, Ki CS, Kim OH, Nishimura G, Unger S, Superti-Furga A, Jin DK. Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia. <span><span class="ref-journal">Hum Genet. </span>2011;<span class="ref-vol">129</span>:497–502.</span> [<a href="/pubmed/21221996" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21221996</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.piters.2010.e1526">Piters E, Culha C, Moester M, van Bezooijen R, Adriaensen D, Mueller T, Weidauer S, Jennes K, de Freitas F, L&#x000f6;wik C, Timmermans JP, Van Hul W, Papapoulos S. First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function. <span><span class="ref-journal">Hum Mutat. </span>2010;<span class="ref-vol">31</span>:E1526–43.</span> [<a href="/pubmed/20583295" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20583295</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.power.2010.1867">Power J, Poole KE, van Bezooijen R, Doube M, Caballero-Al&#x000ed;as AM, Lowik C, Papapoulos S, Reeve J, Loveridge N. Sclerostin and the regulation of bone formation: effects in hip osteoarthritis and femoral neck fracture. <span><span class="ref-journal">J Bone Miner Res. </span>2010;<span class="ref-vol">25</span>:1867–76.</span> [<a href="/pubmed/20200987" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20200987</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.staehlinghampton.2002.144">Staehling-Hampton K, Proll S, Paeper BW, Zhao L, Charmley P, Brown A, Gardner JC, Galas D, Schatzman RC, Beighton P, Papapoulos S, Hamersma H, Brunkow ME. A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">110</span>:144–52.</span> [<a href="/pubmed/12116252" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12116252</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.stein.1983.267">Stein SA, Witkop C, Hill S, Fallon MD, Viernstein L, Gucer G, McKeever P, Long D, Altman J, Miller NR, Teitelbaum SL, Schlesinger S. Sclerosteosis: neurogenetic and pathophysiologic analysis of an American kinship. <span><span class="ref-journal">Neurology. </span>1983;<span class="ref-vol">33</span>:267–77.</span> [<a href="/pubmed/6681869" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6681869</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.van_egmond.2012.740">van Egmond ME, Dikkers FG, Boot AM, van Lierop AH, Papapoulos SE, Brouwer OF. A rare cause of facial nerve palsy in children: hyperostosis corticalis generalisata (Van Buchem disease). Three new pediatric cases and a literature review. <span><span class="ref-journal">Eur J Paediatr Neurol. </span>2012;<span class="ref-vol">16</span>:740–3.</span> [<a href="/pubmed/22445802" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22445802</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.van_lierop.2017.51">van Lierop AH, Appelman-Dijkstra NM, Papapoulos SE. Sclerostin deficiency in humans. <span><span class="ref-journal">Bone. </span>2017;<span class="ref-vol">96</span>:51–62.</span> [<a href="/pubmed/27742500" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27742500</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.van_lierop.2011.2804">van Lierop AH, Hamdy NA, Hamersma H, van Bezooijen RL, Power J, Loveridge N, Papapoulos SE. Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover. <span><span class="ref-journal">J Bone Miner Res. </span>2011;<span class="ref-vol">26</span>:2804–11.</span> [<a href="/pubmed/21786318" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21786318</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.van_lierop.2010.2796">van Lierop AH, Hamdy NA, Papapoulos SE. Glucocorticoids are not always deleterious for bone. <span><span class="ref-journal">J Bone Miner Res. </span>2010;<span class="ref-vol">25</span>:2796–800.</span> [<a href="/pubmed/20549703" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20549703</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.van_lierop.2013.848">van Lierop AH, Hamdy NA, van Egmond ME, Bakker E, Dikkers FG, Papapoulos SE. Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriers. <span><span class="ref-journal">J Bone Miner Res. </span>2013;<span class="ref-vol">28</span>:848–54.</span> [<a href="/pubmed/23074140" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23074140</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.wergedal.2003.5778">Wergedal JE, Veskovic K, Hellan M, Nyght C, Balemans W, Libanati C, Vanhoenacker FM, Tan J, Baylink DJ, Van Hul W. Patients with Van Buchem disease, an osteosclerotic genetic disease, have elevated bone formation markers, higher bone density, and greater derived polar moment of inertia than normal. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2003;<span class="ref-vol">88</span>:5778–83.</span> [<a href="/pubmed/14671168" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14671168</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sost.REF.yagi.2015.1239">Yagi H, Takagi M, Hasegawa Y, Kayserili H, Nishimura G. Sclerosteosis (craniotubular hyperostosis-syndactyly) with complex hyperphalangy of the index finger. <span><span class="ref-journal">Pediatr. Radiol. </span>2015;<span class="ref-vol">45</span>:1239–43.</span> [<a href="/pubmed/25835322" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25835322</span></a>]</div></li></ul></div></div><div id="sost.Chapter_Notes"><h2 id="_sost_Chapter_Notes_">Chapter Notes</h2><div id="sost.Author_History"><h3>Author History</h3><p>Natasha Appelman-Dijkstra, MD, PhD (2019-present)<br />Peter H Beighton, MD, PhD, FRCP, FRCPCH, FRSSA; University of Cape Town (2002-2019)<br />Mary E Brunkow, PhD; Institute for Systems Biology, Seattle (2002-2019)<br />Herman Hamersma, MD; Flora Clinic, Roodepoort (2002-2019)<br />Socrates Papapoulos, MD, PhD (2019-present)<br />Antoon Van Lierop, MD, PhD (2019-present)</p></div><div id="sost.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>21 March 2019 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>10 January 2013 (cd) Revision: prenatal testing for <i>SOST</i> pathogenic variants available clinically</div></li><li class="half_rhythm"><div>12 January 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>5 October 2007 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> available on a clinical basis</div></li><li class="half_rhythm"><div>2 February 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 September 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>4 June 2002 (tk/me) Review posted live</div></li><li class="half_rhythm"><div>5 February 2002 (phb) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1228</span><span class="label">PMID: <a href="/pubmed/20301406" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301406</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/slc6a3-dtds/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/sox2/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1228&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1228/?report=reader">PubReader</a></li><li><a href="/books/NBK1228/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1228" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1228" style="display:none" title="Cite this Page"><div class="bk_tt">Appelman-Dijkstra N, Van Lierop A, Papapoulos S. SOST-Related Sclerosing Bone Dysplasias. 2002 Jun 4 [Updated 2019 Mar 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1228/pdf/Bookshelf_NBK1228.pdf">PDF version of this page</a> (464K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#sost.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#sost.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#sost.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#sost.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#sost.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#sost.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#sost.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#sost.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#sost.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#sost.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#sost.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#sost.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=50964[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SOST</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1478492" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1478492" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1478492" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1478492" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29080811" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models.</a><span class="source">[Metabolism. 2018]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sebastian A, Loots GG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Metabolism. 2018 Mar; 80:38-47. Epub 2017 Oct 25.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/11181578" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).</a><span class="source">[Hum Mol Genet. 2001]</span><div class="brieflinkpop offscreen_noflow">Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Hum Mol Genet. 2001 Mar 1; 10(5):537-43. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/15869924" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene.</a><span class="source">[Bone. 2005]</span><div class="brieflinkpop offscreen_noflow">A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Balemans W, Cleiren E, Siebers U, Horst J, Van Hul W. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Bone. 2005 Jun; 36(6):943-7. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/6673595" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Sclerosteosis involving the temporal bone: clinical and radiologic aspects.</a><span class="source">[Am J Otolaryngol. 1983]</span><div class="brieflinkpop offscreen_noflow">Sclerosteosis involving the temporal bone: clinical and radiologic aspects.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nager GT, Stein SA, Dorst JP, Holliday MJ, Kennedy DW, Diehn KW, Jabs EW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Otolaryngol. 1983 Jan-Feb; 4(1):1-17. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301306" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CLCN7</i>-Related Osteopetrosis</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CLCN7</i>-Related Osteopetrosis<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sobacchi C, Villa A, Schulz A, Kornak U. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301406" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301406" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04175439a66ee2ba2bb7d5">SOST-Related Sclerosing Bone Dysplasias - GeneReviews®</a><div class="ralinkpop offscreen_noflow">SOST-Related Sclerosing Bone Dysplasias - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:13:40-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D611CE0413D510000000001960095&amp;ncbi_session=CE8D611CE0417531_0406SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1228%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1228&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1228/&amp;ncbi_pagename=SOST-Related Sclerosing Bone Dysplasias - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D611CE0417531_0406SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>